Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis

J Biol Chem. 2013 Feb 1;288(5):3240-50. doi: 10.1074/jbc.M112.384776. Epub 2012 Dec 17.

Abstract

3β,16β,17α-Trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranoside (OSW-1) is a natural product with potent antitumor activity against various types of cancer cells, but the exact mechanisms of action remain to be defined. In this study, we showed that OSW-1 effectively killed leukemia cells at subnanomolar concentrations through a unique mechanism by causing a time-dependent elevation of cytosolic Ca(2+) prior to induction of apoptosis. A mechanistic study revealed that this compound inhibited the sodium-calcium exchanger 1 on the plasma membrane, leading to an increase in cytosolic Ca(2+) and a decrease in cytosolic Na(+). The elevated cytosolic Ca(2+) caused mitochondrial calcium overload and resulted in a loss of mitochondrial membrane potential, release of cytochrome c, and activation of caspase-3. Furthermore, OSW-1 also caused a Ca(2+)-dependent cleavage of the survival factor GRP78. Inhibition of Ca(2+) entry into the mitochondria by the uniporter inhibitor RU360 or by cyclosporin A significantly prevented the OSW-1-induced cell death, indicating the important role of mitochondria in mediating the cytotoxic activity. The extremely potent activity of OSW-1 against leukemia cells and its unique mechanism of action suggest that this compound may be potentially useful in the treatment of leukemia.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biological Products / pharmacology*
  • Calcium / metabolism*
  • Calcium Channels / metabolism
  • Calpain / metabolism
  • Caspase 3 / metabolism
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Cholestenones / pharmacology*
  • Cyclosporine / pharmacology
  • Cytochromes c / metabolism
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Drug Screening Assays, Antitumor
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum Chaperone BiP
  • Enzyme Activation / drug effects
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Heat-Shock Proteins / metabolism
  • Homeostasis / drug effects*
  • Humans
  • Leukemia / enzymology
  • Leukemia / metabolism*
  • Leukemia / pathology*
  • Lymphoma / enzymology
  • Lymphoma / pathology
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Saponins / pharmacology*
  • Sodium-Calcium Exchanger / antagonists & inhibitors
  • Sodium-Calcium Exchanger / metabolism
  • Thapsigargin / pharmacology
  • Time Factors

Substances

  • Biological Products
  • Calcium Channels
  • Cholestenones
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • Saponins
  • Sodium-Calcium Exchanger
  • mitochondrial calcium uniporter
  • sodium-calcium exchanger 1
  • OSW 1
  • Thapsigargin
  • Cyclosporine
  • Cytochromes c
  • Calpain
  • Caspase 3
  • Calcium